The University of Southampton
University of Southampton Institutional Repository

Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy

Hobson, Alex R., Petley, Graham, Morton, Geraint, Dawkins, Keith D. and Curzen, Nick P. (2008) Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy Thrombosis Journal, 6 (doi:10.1186/1477-9560-6-1).

Record type: Article

Abstract

ABSTRACT: BACKGROUND: To test the hypothesis that point-of-care assays of platelet reactivity would demonstrate reduced response to antiplatelet therapy in patients who experienced Drug Eluting Stent (DES) ST whilst on dual antiplatelet therapy compared to matched DES controls. Whilst the aetiology of stent thrombosis (ST) is multifactorial there is increasing evidence from laboratory-based assays that hyporesponsiveness to antiplatelet therapy is a factor in some cases. METHODS: From 3004 PCI patients, seven survivors of DES ST whilst on dual antiplatelet therapy were identified and each matched with two patients without ST. Analysis was performed using (a) short Thrombelastogram PlateletMappingtrade mark (TEG) and (b) VerifyNow Aspirin and P2Y12 assays. TEG analysis was performed using the Area Under the Curve at 15 minutes (AUC15) as previously described. RESULTS: There were no differences in responses to aspirin. There was significantly greater platelet reactivity on clopidogrel in the ST group using the Accumetrics P2Y12 assay (183 +/- 51 vs. 108 +/- 31, p = 0.02) and a trend towards greater reactivity using TEG AUC15 (910 +/- 328 vs. 618 +/- 129, p = 0.07). 57% of the ST group by TEG and 43% of the ST cases by Accumetrics PRU had results > two standard deviations above the expected mean in the control group. CONCLUSION: This study demonstrates reduced platelet response to clopidogrel in some patients with DES ST compared to matched controls. The availability of point-of-care assays that can detect these responses raises the possibility of prospectively identifying DES patients at risk of ST and manipulating their subsequent risk.

Full text not available from this repository.

More information

Published date: 29 February 2008
Keywords: function, methods, abstract, risk, therapy, analysis, hypothesis, aspirin, responses

Identifiers

Local EPrints ID: 61221
URI: http://eprints.soton.ac.uk/id/eprint/61221
ISSN: 1477-9560
PURE UUID: 18e6066f-82a5-4147-a67d-ae4e63f36748
ORCID for Graham Petley: ORCID iD orcid.org/0000-0002-3295-0444

Catalogue record

Date deposited: 09 Oct 2008
Last modified: 17 Jul 2017 14:22

Export record

Altmetrics

Contributors

Author: Alex R. Hobson
Author: Graham Petley ORCID iD
Author: Geraint Morton
Author: Keith D. Dawkins
Author: Nick P. Curzen

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×